Over the past 2 decades, a UVA researcher has found new sites in the genome related to type 1 diabetes that could revolutionize screening and therapy.
Author: Luis Soler Rivera (Page 5)
UVA Health’s groundbreaking research finds strong evidence fluoxetine could help slow or prevent the leading cause of blindness in older adults, age-related dry macular degeneration.
Combining robust expertise with the latest robotics improves outcomes and reduces knee replacement revisions.
UVA Health continues to improve the lives of cancer patients with two new focused ultrasound clinical trials for bolstering treatment and pain palliation.